Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

9.5K
Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Translation01:31

Translation

141.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.9K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Alternative RNA Splicing02:18

Alternative RNA Splicing

21.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

226
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
226
Exon Recombination02:32

Exon Recombination

3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Revue neurologique·2026
Same author

Treatment pathway, healthcare resource utilization and direct cost of ALS in France: A nationwide claims database study.

Revue neurologique·2026
Same author

Markers of presymptomatic amyotrophic lateral sclerosis: State of the art, practical implications and perspectives.

Revue neurologique·2025
Same author

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

European journal of neurology·2025
Same author

Could PLS represent a UMN-predominant ALS syndrome?

Revue neurologique·2024
Same author

Spreading of motor neuron degeneration in ALS is not so random.

Revue neurologique·2024

Related Experiment Video

Updated: Jun 28, 2025

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

8.7K

C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?

C Sellier1, P Corcia2, P Vourc'h3

  • 1Centre de recherches en biomédecine de Strasbourg, UMR-S1329, Inserm, université de Strasbourg, Strasbourg, France.

Revue Neurologique
|April 12, 2024
PubMed
Summary

The C9ORF72 gene mutation causes amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD). This review details C9ORF72

Keywords:
Amyotrophic lateral sclerosisC9ORF72PathophysiologyPhenotype

More Related Videos

Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

6.6K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.6K

Related Experiment Videos

Last Updated: Jun 28, 2025

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells
08:53

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells

Published on: May 16, 2017

8.7K
Measuring RAN Peptide Toxicity in C. elegans
10:49

Measuring RAN Peptide Toxicity in C. elegans

Published on: April 30, 2020

6.6K
Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.6K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • The C9ORF72 gene is the most common genetic cause of monogenic amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD).
  • The pathogenic mechanism involves a hexanucleotide repeat expansion (HRE) in the C9ORF72 gene, leading to various downstream cellular dysfunctions.
  • Understanding the genotype-phenotype correlations and disease mechanisms is crucial for developing effective therapeutic strategies.

Purpose of the Study:

  • To provide a comprehensive update on recent clinical, biological, and therapeutic advancements related to C9ORF72.
  • To elucidate the genotype-phenotype correlations in C9ORF72-associated neurological disorders.
  • To explore the molecular mechanisms underlying neuronal death in C9ORF72-related diseases and potential therapeutic avenues.

Main Methods:

  • Literature review of recent studies on C9ORF72 gene mutations.
  • Analysis of clinical data, genetic findings, and biological mechanisms.
  • Synthesis of current understanding of genotype-phenotype relationships and therapeutic strategies.

Main Results:

  • The C9ORF72 HRE is associated with a spectrum of neurological phenotypes beyond classical ALS and FTD.
  • Detailed insights into the molecular pathways contributing to neurodegeneration in C9ORF72 carriers.
  • Emerging therapeutic strategies targeting the C9ORF72 mutation and its consequences.

Conclusions:

  • C9ORF72 hexanucleotide repeat expansions represent a significant genetic factor in neurodegenerative diseases.
  • Further research is needed to fully understand the diverse clinical presentations and underlying pathobiology.
  • Therapeutic interventions targeting C9ORF72 hold promise for patients with these devastating neurological conditions.